Crossmark

circANKRD17(has_circ_0007883) confers paclitaxel resistance of ovarian cancer via interacting with FUS to stabilize FOXR2

Published Online: 2022-09-15

Published Print: 2023-04

Authors

Liang, Yue-Xiu

Zhang, Lian-Ling

Yang, Li https://orcid.org/0000-0001-9549-6333
License Information

Text and Data Mining valid from 2022-09-15

Version of Record valid from 2022-09-15
More Information

Article History

Received: 16 January 2022

Accepted: 26 August 2022

First Online: 15 September 2022

Declarations

:

: The authors declare that there are no conflicts of interest.

: All study on the clinical samples was approved by the Institutional Review Boards of the Affiliated Hospital of Youjiang Medical College for Nationalities. None of the patients had undergone chemotherapy or radiotherapy prior to surgery, and informed consent was obtained from all of the patients.

Document is current